• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

犬类对莱姆病螺旋体外膜蛋白亚单位疫苗和自然感染的体液免疫反应特征

Characterization of canine humoral immune responses to outer surface protein subunit vaccines and to natural infection by Lyme disease spirochetes.

作者信息

Ma J, Bulger P A, Dante S, Davis D R, Perilli-Palmer B, Coughlin R T

机构信息

Cambridge Biotech Corp., Worcester, MA 01605.

出版信息

J Infect Dis. 1995 Apr;171(4):909-15. doi: 10.1093/infdis/171.4.909.

DOI:10.1093/infdis/171.4.909
PMID:7706819
Abstract

Canine antibody responses to Lyme disease subunit vaccines and to natural borrelial infection were investigated. Vaccines were formulated with QS21 and outer surface proteins A (OspA) and B (OspB) derived from Borrelia burgdorferi B31. Vaccines containing QS21 and the lipoproteins gave 4-fold higher IgG1 and 8-fold higher IgG2 antibody responses than without QS21. Antisera to lipidated OspA or OspB vaccines containing QS21 had high antiborrelial activity against isolates B31 and CA-2-87, similar to those with a vaccine containing both OspA and OspB. Only the combination vaccine induced antiborrelial activity against heterologous isolates 24008 Fr and Borrelia garinii G25. Nonlipidated OspA- and OspB-based vaccines with QS21 elicited lower antibody and antiborrelial activity than did lipidated OspA and OspB vaccines; 49% of naturally exposed dogs had low titers to OspA or OspB. Thus, vaccines using lipidated OspA, OspB, and QS21 could induce higher antiborrelial activity than did natural exposure.

摘要

研究了犬对莱姆病亚单位疫苗和自然伯氏疏螺旋体感染的抗体反应。疫苗由QS21以及源自伯氏疏螺旋体B31的外膜蛋白A(OspA)和B(OspB)配制而成。含有QS21和脂蛋白的疫苗产生的IgG1抗体反应比不含QS21的疫苗高4倍,IgG2抗体反应高8倍。含有QS21的脂化OspA或OspB疫苗的抗血清对分离株B31和CA - 2 - 87具有高抗伯氏疏螺旋体活性,类似于含有OspA和OspB的疫苗。只有联合疫苗诱导了针对异源分离株24008 Fr和伽氏疏螺旋体G25的抗伯氏疏螺旋体活性。含QS21的非脂化OspA和OspB疫苗引发的抗体和抗伯氏疏螺旋体活性低于脂化OspA和OspB疫苗;49%自然暴露的犬对OspA或OspB的滴度较低。因此,使用脂化OspA、OspB和QS21的疫苗比自然暴露能诱导更高的抗伯氏疏螺旋体活性。

相似文献

1
Characterization of canine humoral immune responses to outer surface protein subunit vaccines and to natural infection by Lyme disease spirochetes.犬类对莱姆病螺旋体外膜蛋白亚单位疫苗和自然感染的体液免疫反应特征
J Infect Dis. 1995 Apr;171(4):909-15. doi: 10.1093/infdis/171.4.909.
2
Impact of the saponin adjuvant QS-21 and aluminium hydroxide on the immunogenicity of recombinant OspA and OspB of Borrelia burgdorferi.皂苷佐剂QS-21和氢氧化铝对伯氏疏螺旋体重组OspA和OspB免疫原性的影响。
Vaccine. 1994 Aug;12(10):925-32. doi: 10.1016/0264-410x(94)90036-1.
3
Protection of dogs from Lyme disease with a vaccine containing outer surface protein (Osp) A, OspB, and the saponin adjuvant QS21.使用一种含有外表面蛋白(Osp)A、OspB和皂苷佐剂QS21的疫苗保护犬类免受莱姆病侵害。
J Infect Dis. 1995 Apr;171(4):1049-52. doi: 10.1093/infdis/171.4.1049.
4
Immune sera to individual Borrelia burgdorferi isolates or recombinant OspA thereof protect SCID mice against infection with homologous strains but only partially or not at all against those of different OspA/OspB genotype.针对个别伯氏疏螺旋体分离株或其重组外膜蛋白A(OspA)的免疫血清可保护重症联合免疫缺陷(SCID)小鼠免受同源菌株的感染,但对不同OspA/OspB基因型的菌株只能提供部分保护或完全没有保护作用。
Vaccine. 1993;11(10):1049-54. doi: 10.1016/0264-410x(93)90132-h.
5
Borrelia burgdorferi antigens that are targeted by antibody-dependent, complement-mediated killing in the rhesus monkey.在恒河猴中被抗体依赖性补体介导杀伤作用所靶向的伯氏疏螺旋体抗原。
Infect Immun. 1994 Nov;62(11):4929-37. doi: 10.1128/iai.62.11.4929-4937.1994.
6
Characterization of recombinant OspA in two different Borrelia vaccines with respect to immunological response and its relationship to functional parameters.两种不同伯氏疏螺旋体疫苗中重组OspA的免疫反应特征及其与功能参数的关系。
BMC Vet Res. 2018 Oct 16;14(1):312. doi: 10.1186/s12917-018-1625-7.
7
Molecular analysis of neutralizing epitopes on outer surface proteins A and B of Borrelia burgdorferi.伯氏疏螺旋体外表面蛋白A和B上中和表位的分子分析
Infect Immun. 1995 Jun;63(6):2221-7. doi: 10.1128/iai.63.6.2221-2227.1995.
8
Identification of a defined linear epitope in the OspA protein of the Lyme disease spirochetes that elicits bactericidal antibody responses: Implications for vaccine development.莱姆病螺旋体OspA蛋白中可引发杀菌性抗体反应的特定线性表位的鉴定:对疫苗开发的意义。
Vaccine. 2017 May 31;35(24):3178-3185. doi: 10.1016/j.vaccine.2017.04.079. Epub 2017 May 4.
9
Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi.难治性慢性莱姆关节炎与HLA-DR4及对伯氏疏螺旋体OspA和OspB的抗体反应性的关联
Infect Immun. 1993 Jul;61(7):2774-9. doi: 10.1128/iai.61.7.2774-2779.1993.
10
Safety, efficacy, and immunogenicity of a recombinant Osp subunit canine Lyme disease vaccine.重组Osp亚基犬莱姆病疫苗的安全性、有效性和免疫原性。
Vaccine. 1996 Oct;14(14):1366-74. doi: 10.1016/s0264-410x(96)00045-x.

引用本文的文献

1
Vaccine delivery using nanoparticles.疫苗纳米颗粒递送。
Front Cell Infect Microbiol. 2013 Mar 25;3:13. doi: 10.3389/fcimb.2013.00013. eCollection 2013.
2
Vaccines for canine leishmaniasis.犬利什曼病疫苗。
Front Immunol. 2012 Apr 17;3:69. doi: 10.3389/fimmu.2012.00069. eCollection 2012.
3
Antibodies against specific proteins of and immobilizing activity against three strains of Borrelia burgdorferi sensu lato can be found in symptomatic but not in infected asymptomatic dogs.在出现症状的犬类中可发现针对莱姆病螺旋体狭义种三种菌株特定蛋白质的抗体以及对其的固定活性,但在受感染却无症状的犬类中则未发现。
J Clin Microbiol. 2000 Jul;38(7):2611-21. doi: 10.1128/JCM.38.7.2611-2621.2000.
4
Adjuvanted Lyme disease vaccine: a review of its use in the management of Lyme disease.佐剂性莱姆病疫苗:其在莱姆病管理中的应用综述
Drugs. 2000 Feb;59(2):281-99. doi: 10.2165/00003495-200059020-00019.